Drug Resistance Profiles of Mycobacterium tuberculosis Complex and Factors Associated with Drug Resistance in the Northwest and Southwest Regions of Cameroon

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Meriki, Henry D ^a   Tufon, Kukwah A ^a   Atanga, Pascal N ^a,b   Ane Anyangwe, Irene N ^a   Anong, Damian N ^a   Cho Ngwa, Fidelis ^a   Nkuo Akenji, Theresa ^a  

^a UNIVERSITY OF BUEA   (Cameroon)

^b Regional Delegation of Public Health   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; CAMEROON; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCOME; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CAMEROON; COINFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84885820032     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077410     Document Type: Article

References (45)

1. Wallis RS, Wang C, Doherty TM, Onyebujoh P, Vahedi M, et al. (2009) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 10: 162-172. PubMed: 2011397219246020.
2. Bekker LG, Wood R, (2010) The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis 50 (Suppl 3):: S208-S214. doi:10.1086/651493. PubMed: 20397950.
3. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, et al. (1989) A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. N Engl J Med 320: 545-550. doi:10.1056/NEJM198903023200901. PubMed: 2915665.
4. Sia IG, Wieland ML, (2011) Current concepts in the management of tuberculosis. Mayo Clin Proc 86: 348-361. doi:10.4065/mcp.2010.0820. PubMed: 21454737.
5. World Health Organisation (2012) Global Tuberculosis Report 2012. WHO Geneva: Library Cataloguing-in-Publication Data; World Health Organisation, WHO/HTM/TB/2012.6.
6. Institut National de la Statistique Ministère de l'Économie de la Planification et de l'Aménagement du Territoire Ministère de la Santé Publique Yaoundé, Cameroun (2011). nquête Démographique et de Santé et à Indicateurs Multiples (EDS-MICS) 2011.
7. Bureau Central des Recensements et des Etudes de la Population (BUCREP) (2010). ème Recensement Général de la population et de l'Habitat (3e RGPH): La Population du Cameroun en 2010.
8. The National Tuberculosis Control Programme, Southwest Regional Delegation of Public Health, Buea, Cameroon. (2012) egional Tuberculosis Control Unit Annual Report.
9. The National Tuberculosis Control Programme, Northwest Regional Delegation of Public Health, Bamenda, Cameroon. (2012) Regional Tuberculosis Control Unit Annual Report.
10. Jackson S, Sleigh AC, Wang GJ, Liu XL, (2006) Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis 10: 1104-1110. PubMed: 17044202.
11. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, et al. (2011) The social determinants of tuberculosis: from evidence to action. Am J Public Health 101: 654-662. doi:10.2105/AJPH.2010.199505. PubMed: 21330583.
12. Skolnik NS, Wiedemann AT, Bates B, (2005) Helping Patients Who Drink Too Much: A clinical guide. 5th ed. National Institute on Alcohol Abuse and Alcoholism.
13. Niemann S, Richter E, Rüsch-Gerdes S, (2000) Differentiation among Members of the Mycobacterium tuberculosis Complex by Molecular and Biochemical Features: Evidence for Two Pyrazinamide-Susceptible Subtypes of M. bovis. J Clin Microbiol 38: 152-157. PubMed: 10618079.
14. Canetti G, Fox W, Khomenko A, (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41: 21-43. PubMed: 5309084.
15. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021. doi:10.1001/archinte.163.9.1009. PubMed: 12742798.
16. Bercion R, Kuaban C, (1998) Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon. Bull Soc Pathol Exot 199091:: 199-202.
17. Assam-Assam JP, Penlap VB, Cho-Ngwa F, Tedom JC, Ane-Anyangwe I, et al. (2011) Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect Dis 11: 94. doi:10.1186/1471-2334-11-94. PubMed: 21496268.
18. Kuaban C, Bercion R, Noeske J, Cunin P, Nkamsse P, et al. (2000) Anti-tuberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis 4: 356-360. PubMed: 10777086.
19. Lukoye D, Cobelens FGJ, Ezati N, Kirimunda S, Adatu FE, et al. (2011) Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection. PLOS ONE 6: 7.
20. Sethi S, Mewara A, Dhatwalia SK, Singh H, Yadav R, et al. (2013) Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis 13: 137. doi:10.1186/1471-2334-13-137. PubMed: 23497169.
21. Paramasivan CN, Venkataraman P, (2004) Drug resistance in tuberculosis in India. Indian J Med Res 120: 377-386. PubMed: 15520487.
22. Noeske J, Voelz N, Fon E, Abena Foe JL, (2012) Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. BMC Res Notes 5: 160. doi:10.1186/1756-0500-5-160. PubMed: 22436423.
23. Haar CH, Cobelens FG, Kalisvaart NA, Van Der Have JJ, Van Gerven PJ, et al. (2007) Tuberculosis Drug Resistance and HIV Infection, the Netherlands. Emerg Infect Dis 13: 776-778. doi:10.3201/eid1305.060334. PubMed: 17553264.
24. Holmes CB, Hausler H, Nunn P, (1998) A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis 2: 96-104. PubMed: 9562118.
25. Crampin AC, Glynn JR, Floyd S, Malema SS, Mwinuka VK, et al. (2004) Tuberculosis and gender: exploring the patterns in a case control study in Malawi. Int J Tuberc Lung Dis 8: 194-203. PubMed: 15139448.
26. Fätkenheuer G, Taelman H, Lepage P, Schwenk A, Wenzel R, (1999) The return of tuberculosis. Diagn Microbiol Infect Dis 34: 139-146. doi:10.1016/S0732-8893(99)00006-1. PubMed: 10354864.
27. World Health Organization (2004) TB/HIV: A clinical manual. Stop TB Department Department of HIV/AIDS Department of Child and Adolescent Health and Development. 2nd ed. Geneva: WHO Library Cataloguing-in-Publication Data. WHO/HTM/TB/2004.329 TB.
28. Harper M, Ahmadu FA, Ogden JA, McAdam KP, Lienhardt C, (2003) Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia. Trans R Soc Trop Med Hyg 97: 506-510. doi:10.1016/S0035-9203(03)80007-X. PubMed: 15307411.
29. Glynn JR, Warndorff DK, Malema SS, Mwinuka V, Pönnighaus JM, et al. (2000) Tuberculosis: associations with HIV and socioeconomic status in rural Malawi. Trans R Soc Trop Med Hyg 94: 500-503. doi:10.1016/S0035-9203(00)90065-8. PubMed: 11132374.
30. Liu JJ, Yao HY, Liu EY, (2005) Analysis of factors affecting the epidemiology of tuberculosis in China. Int J Tuberc Lung Dis 9: 450-454. PubMed: 15830752.
31. Narasimhan P, Wood J, Macintyre CR, Mathai D, (2013) Risk factors for tuberculosis. Pulm Med,(2013). Article ID: pp. 11, 23476764.
32. Joshi R, Reingold AL, Menzies D, Pai M, (2006) Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLOS Med 3: e494. doi:10.1371/journal.pmed.0030494. PubMed: 17194191.
33. Golub JE, (2001) Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Arch Intern Med 161: 2254-2258. doi:10.1001/archinte.161.18.2254. PubMed: 11575983.
34. Marais BJ, Obihara CC, Warren RM, Schaaf HS, Gie RP, et al. (2005) The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis 9: 1305-1313. PubMed: 16466051.
35. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR, (2007) Risk of Tuberculosis From Exposure to Tobacco Smoke. Ach. Intern Med 167: 335-342. doi:10.1001/archinte.167.4.335.
36. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C, (2008) Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health 8: 289. doi:10.1186/1471-2458-8-289. PubMed: 18702821.
37. Gajalakshmi V, Peto R, (2009) Smoking, drinking and incident tuberculosis in rural India: population-based case-control study. Int J Epidemiol 38: 1018-1025. doi:10.1093/ije/dyp225. PubMed: 19498083.
38. Suthar AB, Lawn SD, Del Amo J, Getahun H, Dye C, et al. (2012) Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis. PLOS Med 9: e1001270.
39. Del Amo J, Moreno S, Bucher H, Furrer H, Logan R, et al. (2012) Impact of Antiretroviral Therapy on Tuberculosis Incidence Among HIV-Positive Patients in High-Income Countries. Clin Infect Dis 54: 1364-1372. doi:10.1093/cid/cis203. PubMed: 22460971.
40. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, et al. (2000) Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14: 1985-1991. doi:10.1097/00002030-200009080-00015. PubMed: 10997404.
41. Daniel O, Osman E, (2011) Prevalence and risk factors associated with drug resistant TB in SouthWest Nigeria. Asian Pacific J Trop Med 4: 148-151.
42. Faustini A, Hall AJ, Perucci CA, (2006) Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61: 158-163. doi:10.1136/thx.2005.045963. PubMed: 16254056.
43. Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, et al. (2009) Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis 13: 68-73. PubMed: 19105881.
44. World Health Organization (2008) Anti-tuberculosis drugs in the World. Fourth Global Report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. Geneva:World Health Organisation. WHO/HTM/TB/2008.394.
45. Suchindran S, Brouwer ES, Van Rie A, (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLOS ONE 4: e5561. doi:10.1371/journal.pone.0005561. PubMed: 19440304.